Front Row Advisors LLC - PROGENICS PHARMACEUTICALS IN ownership

Back to all holdings Add to watchlist

PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 137 filers reported holding PROGENICS PHARMACEUTICALS IN in Q3 2019. The put-call ratio across all filers is 0.37 and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
Front Row Advisors LLC ownership history of PROGENICS PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2020$0
-100.0%
1000.0%0.00%
-100.0%
Q4 2019$1,0000.0%1000.0%0.00%0.0%
Q3 2019$1,0000.0%1000.0%0.00%0.0%
Q2 2019$1,000–1000.0%0.00%–
Q1 2019$0–100–0.00%–
 Download
Other shareholders

There were no reported owners of PROGENICS PHARMACEUTICALS IN in Q3 2019.

NameSharesValueWeighting ↓
View complete list of PROGENICS PHARMACEUTICALS IN shareholders